tiprankstipranks
Advertisement
Advertisement

VYNE Stock Latest News

VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
Company AnnouncementsVYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
5d ago
8K
VYNE
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
PremiumCompany Announcements
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
3M ago
8K
VYNE
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
PremiumCompany Announcements
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
4M ago
8K
VYNE
3 Penny Stocks to Watch Now, 12/18/25
PremiumMarket News
3 Penny Stocks to Watch Now, 12/18/25
5M ago
BEAT
VYNE
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
PremiumRatings
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
5M ago
VYNE
VYNE Therapeutics Announces Merger with Yarrow Bioscience
PremiumCompany AnnouncementsVYNE Therapeutics Announces Merger with Yarrow Bioscience
5M ago
8K
VYNE
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
Premium
The Fly
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
5M ago
VYNE
VYNE Therapeutics Approves Director Elections and Proposals
Premium
Company Announcements
VYNE Therapeutics Approves Director Elections and Proposals
6M ago
8K
VYNE
VYNE Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
VYNE Therapeutics Reports Q3 2025 Financial Results
7M ago
VYNE
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
PremiumThe Fly
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
7M ago
VYNE
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
9M ago
8K
VYNE
VYNE Therapeutics Reports Q2 2025 Financials and Updates
PremiumCompany Announcements
VYNE Therapeutics Reports Q2 2025 Financials and Updates
10M ago
VYNE
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
PremiumRatingsVYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
10M ago
VYNE
VYNE Therapeutics Directors Resign Amid Financial Updates
Premium
Company Announcements
VYNE Therapeutics Directors Resign Amid Financial Updates
10M ago
8K
VYNE
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
Premium
The Fly
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
10M ago
VYNE
VYNE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VYNE Earnings this Week: How Will it Perform?
10M ago
VYNE
Watch Out! Analysts Have Recently Downgraded These Stocks
PremiumMarket News
Watch Out! Analysts Have Recently Downgraded These Stocks
10M ago
AMD
NEO
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
PremiumMarket News
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
10M ago
VYNE
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe Fly
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
10M ago
VYNE
VYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
PremiumRatingsVYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
10M ago
VYNE
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
10M ago
MO
QS
VYNE Therapeutics downgraded at H.C. Wainwright after vitiligo trial miss
Premium
The Fly
VYNE Therapeutics downgraded at H.C. Wainwright after vitiligo trial miss
10M ago
VYNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >